Towards mapping the brain connectome in depression: Functional connectivity by perfusion SPECT

Psychiatry Research - Neuroimaging

Volumn 223, Issue 2, 2014, Pages 171-177

  Gardner, Ann ^a,b   Åstrand, Disa ^c   Öberg, Johanna ^c   Jacobsson, Hans ^c   Jonsson, Cathrine ^c   Larsson, Stig ^c   Pagani, Marco ^c,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Järva Psychiatric Out patient Clinic   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d INSTITUTE OF COGNITIVE SCIENCES AND TECHNOLOGIES   (Italy)

Author keywords

Caudate; Cerebellum; Chronic depression; Mitochondrial impairment; Persistent depressive disorder

Indexed keywords

ADULT; ARTICLE; BRAIN BLOOD FLOW; BRAIN CONNECTOME; BRAIN FUNCTION; BRAIN MAPPING; BRAIN PERFUSION; CAUDATE NUCLEUS; CEREBELLUM; CONNECTOME; CONTROLLED STUDY; DECISION MAKING; DEPRESSION; FEMALE; FUNCTIONAL NEUROIMAGING; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVOUS SYSTEM PARAMETERS; PRIORITY JOURNAL; RESTING STATE NETWORK; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL PARAMETRIC MAPPING; VOXEL BASED MORPHOMETRY; CASE CONTROL STUDY; CHRONIC DISEASE; DEPRESSIVE DISORDER; MIDDLE AGED; PATHOPHYSIOLOGY; PERFUSION; PROCEDURES; SCINTISCANNING;

PSYCHOTROPIC AGENT;

ADULT; BRAIN MAPPING; CASE-CONTROL STUDIES; CAUDATE NUCLEUS; CEREBELLUM; CHRONIC DISEASE; CONNECTOME; DEPRESSION; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; PERFUSION; PSYCHOTROPIC DRUGS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84903820249     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2014.05.008     Document Type: Article

References (65)

1. Abe O., Yamasue H., Kasai K., Yamada H., Aoki S., Inoue H., Takei K., Suga M., Matsuo K., Kato T., Masutani Y., Ohtomo K. Voxel-based analyses of gray/white matter volume and diffusion tensor data in major depression. Psychiatry Research: Neuroimaging 2010, 181:64-70.
2. Alexopoulos G.S., Hoptman M.J., Yuen G., Kanellopoulos D.K., Seirup J., Lim K.O., Gunning F.M. Functional connectivity in apathy of late-life depression: a preliminary study. Journal of Affective Disorders 2013, 149:398-405.
3. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2013, American Psychiatric Association, Arlington, VA. fifth edition.
4. Baillieux H., De Smet H.J., Paquier P.F., De Deyn P.P., Mariën P. Cerebellar neurocognition: insights into the bottom of the brain. Clinical Neurology and Neurosurgery 2008, 110:763-773.
5. Balleine B.W., O'Doherty J.P. Human and rodent homologies in action control: corticostriatal determinants of goal-directed and habitual action. Neuropsychopharmacology 2010, 35:48-69.
6. Baxter L.R., Phelps M.E., Mazziotta J.C., Schwartz J.M., Gerner R.H., Selin C.E., Sumida R.M. Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18. Archives of General Psychiatry 1985, 42:441-447.
7. Bluhm R., Williamson P., Lanius R., Théberge J., Densmore M., Bartha R., Neufeld R., Osuch E. Resting state default-mode network connectivity in early depression using a seed region-of-interest analysis: decreased connectivity with caudate nucleus. Psychiatry and Clinical Neurosciences 2009, 63:754-761.
8. Bookheimer S.Y., Strojwas M.H., Cohen M.S., Saunders A.M., Pericak-Vance M.A., Mazziotta J.C., Small G.W. Patterns of brain activation in people at risk for Alzheimer[U+05F3]s disease. New England Journal of Medicine 2000, 343:450-456.
9. Broadbent D., Cooper P.F., Fitzgerald P., Parkes K.R. The cognitive failures questionnaire (CFQ) and its correlates. British Journal of Clinical Psychology 1982, 21:1-16.
10. Butters M.A., Aizenstein H.J., Hayashi K.M., Meltzer C.C., Seaman J., Reynolds C.F., Toga A.W., Thompson P.M., Becker J.T. Three-dimensional surface mapping of the caudate nucleus in late-life depression. American Journal of Geriatric Psychiatry 2009, 17:4-12.
11. Chen Y., Wan H.I., O'Reardon J.P., Wang D.J., Wang Z., Korczykowski M., Detre J.A. Quantification of cerebral blood flow as biomarker of drug effect: arterial spin labeling phMRI after a single dose of oral citalopram. Clinical and Pharmacological Therapy 2011, 89:251-258.
12. Damoiseaux J.S., Rombouts S.A., Barkhof F., Scheltens P., Stam C.J., Smith S.M., Beckmann C.F. Consistent resting-state networks across healthy subjects. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:13848-13853.
13. Delbeuck X., Van der Linden M., Collette F. Alzheimer's disease as a disconnection syndrome?. Neuropsychology Review 2003, 13:79-92.
14. Delonlay P., Rötig A., Sarnat H.B. Respiratory chain deficiencies. Handbook of Clinical Neurology 2013, 113:1651-1666.
15. Drzezga A., Grimmer T., Peller M., Wermke M., Siebner H., Rauschecker J.P., Schwaiger M., Kurz A. Impaired cross-modal inhibition in Alzheimer disease. PLOS Medicine 2005, 2:e288.
16. Filosto M., Tonin P., Vattemi G., Spagnolo M., Rizzuto N., Tomelleri G. Antioxidant agents have a different expression pattern in muscle fibers of patients with mitochondrial diseases. Acta Neuropathologica 2002, 103:215-220.
17. Fitzgerald P.B., Laird A.R., Maller J., Daskalakis Z.J. A meta-analytic study of changes in brain activation in depression. Human Brain Mapping 2008, 29:683-695.
18. Folstein M.F., Folstein S.E., McHugh P.R. 'Mini-mental state', a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975, 12:189-198.
19. Fornito A., Bullmore E.T. Connectomic intermediate phenotypes for psychiatric disorders. Frontiers of Psychiatry 2012, 3:32.
20. Fournier J.C., DeRubeis R.J., Shelton R.C., Hollon S.D., Amsterdam J.D., Gallop R. Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression. Journal of Consulting and Clinical Psychology 2009, 77:775-787.
21. Friedman S.D., Shaw D.W., Ishak G., Gropman A.L., Saneto R.P. The use of neuroimaging in the diagnosis of mitochondrial disease. Developmental Disabilities Research Reviews 2010, 16:129-135.
22. Gardner A., Boles R.G. Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011, 35:730-743.
23. Gardner A., Johansson A., Wibom R., Nennesmo I., von Döbeln U., Hagenfeldt L., Hällström T. Alterations of mitochondrial function and correlations with personality traits in selected major depressive disorder patients. Journal of Affective Disorders 2003, 76:55-68.
24. Gardner A., Salmaso D., Nardo D., Micucci F., Nobili F., Sanchez-Crespo A., Jacobsson H., Larsson S.A., Pagani M. Mitochondrial function is related to alterations at brain SPECT in depressed patients. CNS Spectrums 2008, 13:805-814.
25. Grealy M.A., Lee D.N. An automatic-voluntary dissociation and mental imagery disturbance following a cerebellar lesion. Neuropsychologia 2011, 49:271-275.
26. Haas R., Dietrich R. Neuroimaging of mitochondrial disorders. Mitochondrion 2004, 4:471-490.
27. Habas C., Kamdar N., Nguyen D., Prater K., Beckmann C.F., Menon V., Greicius M.D. Distinct cerebellar contributions to intrinsic connectivity networks. Journal of Neuroscience 2009, 29:8586-8594.
28. Hagmann P., Grant P.E., Fair D.A. MR connectomics: a conceptual framework for studying the developing brain. Frontiers in Systems Neuroscience 2012, 6:43.
29. Hagmann P., Cammoun L., Gigandet X., Gerhard S., Grant P.E., Wedeen V., Meuli R., Thiran J.P., Honey C.J., Sporns O. MR connectomics: principles and challenges. Journal of Neuroscience Methods 2010, 194:34-45.
30. Horn G.L. An investigation into the effects of cognitive behavioral therapy on patients with chronic depression: a small case series. Journal of Psychology Research and Behavior Management 2012, 5:123-129.
31. Hwang J.P., Lee T.W., Tsai S.J., Chen T.J., Yang C.H., Lirng J.F., Tsai C.F. Cortical and subcortical abnormalities in late-onset depression with history of suicide attempts investigated with MRI and voxel-based morphometry. Journal of Geriatric Psychiatry and Neurology 2010, 23:171-184.
32. Kelly C., Biswal B.B., Craddock R.C., Castellanos F.X., Milham M.P. Characterizing variation in the functional connectome: promise and pitfalls. Trends in Cognitive Sciences 2012, 16:181-188.
33. Lax N.Z., Hepplewhite P.D., Reeve A.K., Nesbitt V., McFarland R., Jaros E., Taylor R.W., Turnbull D.M. Cerebellar ataxia in patients with mitochondrial DNA disease: a molecular clinicopathological study. Journal of Neuropathology and Experimental Neurology 2012, 71:148-161.
34. Lee D.S., Kang H., Kim H., Park H., Oh J.S., Lee J.S., Lee M.C. Metabolic connectivity by interregional correlation analysis using statistical parametric mapping (SPM) and FDG brain PET; methodological development and patterns of metabolic connectivity in adults. European Journal of Nuclear Medicine and Molecular Imaging 2008, 35:1681-1691.
35. Leibenluft E., Pine D.S. Resting state functional connectivity and depression: in search of a bottom line. Biological Psychiatry 2013, 74:868-869.
36. Lépine J.P., Briley M. The epidemiology of pain in depression. Human Psychopharmacology 2004, 19(Suppl. 1):S3-S7.
37. Liu L., Zeng L.L., Li Y., Ma Q., Li B., Shen H., Hu D. Altered cerebellar functional connectivity with intrinsic connectivity networks in adults with major depressive disorder. PLOS One 2012, 7:e39516.
38. Lorenzetti V., Allen N.B., Fornito A., Yücel M. Structural brain abnormalities in major depressive disorder: a selective review of recent MRI studies. Journal of Affective Disorders 2009, 117:1-17.
39. Lui S., Wu Q., Qiu L., Yang X., Kuang W., Chan R.C., Huang X., Kemp G.J., Mechelli A., Gong Q. Resting-state functional connectivity in treatment-resistant depression. American Journal of Psychiatry 2011, 168:642-648.
40. Ma Q., Zeng L.L., Shen H., Liu L., Hu D. Altered cerebellar-cerebral resting-state functional connectivity reliably identifies major depressive disorder. Brain Research 2013, 1495:86-94.
41. MacQueen G.M., Galway T.M., Hay J., Young L.T., Joffe R.T. Recollection memory deficits in patients with major depressive disorder predicted by past depressions but not current mood state or treatment status. Psychological Medicine 2002, 32:251-258.
42. Manji H., Kato T., Di Prospero N.A., Ness S., Beal M.F., Krams M., Chen G. Impaired mitochondrial function in psychiatric disorders. Nature Reviews Neuroscience 2012, 13:293-307.
43. Monkul E.S., Silva L.A., Narayana S., Peluso M.A., Zamarripa F., Nery F.G., Najt P., Li J., Lancaster J.L., Fox P.T., Lafer B., Soares J.C. Abnormal resting state corticolimbic blood flow in depressed unmedicated patients with major depression: a (15)O-H(2)O PET study. Human Brain Mapping 2012, 33:272-279.
44. Montero R., Pineda M., Aracil A., Vilaseca M.A., Briones P., Sánchez-Alcázar J.A., Navas P., Artuch R. Clinical, biochemical and molecular aspects of cerebellar ataxia and Coenzyme Q10 deficiency. Cerebellum 2007, 6:118-122.
45. Montgomery S.A., Åsberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 1979, 134:382-389.
46. Morbelli S., Drzezga A., Perneczky R., Frisoni G.B., Caroli A., van Berckel B.N.M., Ossenkoppele R., Guedj E., Didic M., Brugnolo A., Sambuceti G., Pagani M., Salmon E., Nobili F. Resting metabolic connectivity in prodromal Alzheimer[U+05F3]s disease. A European Alzheimer Disease Consortium (EADC) Project. Neurobiology of Aging 2012, 33:2533-2550.
47. Morbelli S., Perneczky R., Drzezga A., Frisoni G.B., Caroli A., van Berckel B.N.M., Ossenkoppele R., Guedj E., Didic M., Brugnolo A., Naseri M., Sambuceti G., Pagani M., Nobili F. Metabolic networks underlying cognitive reserve in prodromal Alzhemer[U+05F3]s disease: a European Alzheimer[U+05F3]s disease consortium project. Journal of Nuclear Medicine 2013, 54:894-902.
48. 18F-FDG PET study on normal aging and Alzheimer[U+05F3]s disease. Journal of Nuclear Medicine 2004, 45:382-392.
49. Murphy J.A., Byrne G.J. Prevalence and correlates of the proposed DSM-5 diagnosis of chronic depressive disorder. Journal of Affective Disorders 2012, 139:172-180.
50. Nardo D, Högberg G, Flumeri F, Jacobsson H, Larsson SA, Hällström T, Pagani M. Self-rating scales assessing subjective well-being and distress correlate with rCBF in PTSD-sensitive regions. Psychological Medicine 2011, 41:2549-2561.
51. Nikolaus S., Larisch R., Beu M., Vosberg H., Müller-Gärtner HW. Diffuse cortical reduction of neuronal activity in unipolar major depression: a retrospective analysis of 337 patients and 321 controls. Nuclear Medicine Communications 2000, 21:1119-1125.
52. Nobili F., Salmaso D., Morbelli S., Girtler N., Piccardo A., Brugnolo A., Villavecchia G., Dessi B., Larsson S.A., Rodriguez G., Pagani M. Principal component analysis of FDG PET in amnestic MCI. European Journal of Nuclear Medicine and Molecular Imaging 2008, 35:2191-2202.
53. Pagani M., Salmaso D., Rodriguez G., Nardo D., Nobili F. Principal Component Analysis in mild and moderate Alzheimer[U+05F3]s Disease. Psychiatry Research: Neuroimaging 2009, 173:8-14.
54. Papo D. Why should cognitive neuroscientists study the brain[U+05F3]s resting state?. Frontiers of Human Neuroscience 2013, 7:45.
55. Pillay S.S., Renshaw P.F., Bonello C.M., Lafer B.C., Fava M., Yurgelun-Todd D. A quantitative magnetic resonance imaging study of caudate and lenticular nucleus gray matter volume in primary unipolar major depression: relationship to treatment response and clinical severity. Psychiatry Research: Neuroimaging 1998, 84:61-74.
56. Pillay S.S., Yurgelun-Todd D.A., Bonello C.M., Lafer B., Fava M., Renshaw P.F. A quantitative magnetic resonance imaging study of cerebral and cerebellar gray matter volume in primary unipolar major depression: relationship to treatment response and clinical severity. Biological Psychiatry 1997, 42:79-84.
57. Porcelli A.J., Lewis A.H., Delgado M.R. Acute stress influences neural circuits of reward processing. Frontiers in Neuroscience 2012, 6:157.
58. Schatz G. A Matter of Wonder. What Biology Reveals About Us, Our World, and Our Dreams 2011, 170. Karger AG, Switzerland.
59. Scheuerecker J., Meisenzahl E.M., Koutsouleris N., Roesner M., Schöpf V., Linn J., Wiesmann M., Brückmann H., Möller H.J., Frodl T. Orbitofrontal volume reductions during emotion recognition in patients with major depression. Journal of Psychiatry and Neuroscience 2010, 35:311-320.
60. Schmahmann J.D. Disorders of the cerebellum: ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome. Journal of Neuropsychiatry and Clinical Neurosciences 2004, 16:367-378.
61. Shad M.U., Muddasani S., Rao U. Gray matter differences between healthy and depressed adolescents: a voxel-based morphometry study. Journal of Child and Adolescent Psychopharmacology 2012, 22:190-197.
62. Sheline Y.I., Price J.L., Yan Z., Mintun M.A. Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexus. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:11020-11025.
63. Xie T., He Y. Mapping the Alzheimer[U+05F3]s brain with connectomics. Frontiers of Psychiatry 2012, 2:77.
64. Zeng L.L., Liu L., Liu Y., Shen H., Li Y., Hu D. Antidepressant treatment normalizes white matter volume in patients with major depression. PLOS One 2012, 7:e44248.
65. Zeng L.L., Shen H., Liu L., Wang L., Li B., Fang P., Zhou Z., Li Y., Hu D. Identifying major depression using whole-brain functional connectivity: a multivariate pattern analysis. Brain 2012, 135:1498-1507.